{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:05:32Z","timestamp":1777593932736,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>The prevalence of hyperthyroidism in Pakistan is 2.9%, which is two times higher than in the United States. Most high-quality hyperthyroidism clinical practice guidelines (CPGs) used internationally originate from high-income countries in the West. Local CPGs in Pakistan are not backed by transparent methodologies. We aimed to produce comprehensive, high-quality CPGs for the management of hyperthyroidism in Pakistan.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We employed the GRADE-ADOLOPMENT approach utilizing the <jats:italic>2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis<\/jats:italic> as the source CPG. Recommendations from the source guideline were either adopted as is, excluded, or adapted according to our local context.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The source guideline included a total of 124 recommendations, out of which 71 were adopted and 49 were excluded. 4 recommendations were carried forward for adaptation via the ETD process, with modifications being made to 2 of these. The first addressed the need for liver function tests (LFTs) amongst patients experiencing symptoms of hepatotoxicity while being treated with anti-thyroid drugs (ATDs). The second pertained to thyroid status testing post-treatment by radioactive iodine (RAI) therapy for Graves\u2019 Disease (GD). Both adaptations centered around the judicious use of laboratory investigations to reduce costs of hyperthyroidism management.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our newly developed hyperthyroidism CPGs for Pakistan contain two context-specific modifications that prioritize patients\u2019 finances during the course of hyperthyroidism management and to limit the overuse of laboratory testing in a resource-constrained setting. Future research must investigate the cost-effectiveness and risk-benefit ratio of these modified recommendations.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12902-023-01493-1","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T04:38:03Z","timestamp":1710995883000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["GRADE-ADOLOPMENT of hyperthyroidism treatment guidelines for a Pakistani context"],"prefix":"10.1186","volume":"24","author":[{"given":"Russell Seth","family":"Martins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Nadeem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abeer","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajjan","family":"Raja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina","family":"Pervez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najmul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asma","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aisha","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saira","family":"Furqan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanik","family":"Ram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azra","family":"Rizwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nashia Ali","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsin Ali","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salima Saleem","family":"Aamdani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bushra","family":"Ayub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Qamar","family":"Masood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,21]]},"reference":[{"issue":"5","key":"1493_CR1","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrendo.2018.18","volume":"14","author":"PN Taylor","year":"2018","unstructured":"Taylor PN, Albrecht D, Scholz A, Gutierrez-Buey G, Lazarus JH, Dayan CM, et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol. 2018;14(5):301\u201316.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"1493_CR2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.emc.2013.12.001","volume":"32","author":"D Devereaux","year":"2014","unstructured":"Devereaux D, Tewelde SZ. Hyperthyroidism and thyrotoxicosis. Emerg Med Clin. 2014;32(2):277\u201392.","journal-title":"Emerg Med Clin"},{"key":"1493_CR3","unstructured":"Initiatives MoPDS. Pakistan population situation analysis. Pakistan: UNFPA; 2020."},{"key":"1493_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3923\/jms.2001.153.156","volume":"1","author":"S Akhter","year":"2001","unstructured":"Akhter S, Khan A, Siddiqui MM, Nawab G. Frequencies of thyroid problems in different age, sex and seasons. J Med Sci. 2001;1:153\u20136.","journal-title":"J Med Sci"},{"issue":"2","key":"1493_CR5","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","volume":"87","author":"JG Hollowell","year":"2002","unstructured":"Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489\u201399.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1493_CR6","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1210\/jc.2013-2409","volume":"99","author":"A Garmendia Madariaga","year":"2014","unstructured":"Garmendia Madariaga A, Santos Palacios S, Guill\u00e9n-Grima F, Galofr\u00e9 JC. The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab. 2014;99(3):923\u201331.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1493_CR7","doi-asserted-by":"publisher","first-page":"347","DOI":"10.4103\/2230-8210.152768","volume":"19","author":"A Jawa","year":"2015","unstructured":"Jawa A, Jawad A, Riaz SH, Assir MZ, Chaudhary AW, Zakria M, et al. Turmeric use is associated with reduced goitrogenesis: thyroid disorder prevalence in Pakistan (THYPAK) study. Indian J Endocrinol Metab. 2015;19(3):347\u201350.","journal-title":"Indian J Endocrinol Metab"},{"issue":"7","key":"1493_CR8","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1210\/jc.2013-4184","volume":"99","author":"C Selmer","year":"2014","unstructured":"Selmer C, Olesen JB, Hansen ML, von Kappelgaard LM, Madsen JC, Hansen PR, et al. Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events: a large population study. J Clin Endocrinol Metab. 2014;99(7):2372\u201382.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1493_CR9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1089\/thy.2009.0321","volume":"20","author":"MR Haymart","year":"2010","unstructured":"Haymart MR. The role of clinical guidelines in patient care: thyroid hormone replacement in women of reproductive age. Thyroid. 2010;20(3):301\u20137.","journal-title":"Thyroid"},{"key":"1493_CR10","unstructured":"Mestman JH. How effective are clinical guidelines for hypothyroidism in pregnancy in clinical practice?\u00a0Clin Thyroidol. 2013;25:194\u20136."},{"issue":"10","key":"1493_CR11","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/thy.2016.0229","volume":"26","author":"DS Ross","year":"2016","unstructured":"Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26(10):1343\u2013421.","journal-title":"Thyroid"},{"issue":"4","key":"1493_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000490384","volume":"7","author":"GJ Kahaly","year":"2018","unstructured":"Kahaly GJ, Bartalena L, Heged\u00fcs L, Leenhardt L, Poppe K, Pearce SH. 2018 European thyroid Association Guideline for the management of Graves\u2019 hyperthyroidism. Eur Thyroid J. 2018;7(4):167\u201386.","journal-title":"Eur Thyroid J"},{"key":"1493_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jclinepi.2016.09.009","volume":"81","author":"HJ Sch\u00fcnemann","year":"2017","unstructured":"Sch\u00fcnemann HJ, Wiercioch W, Brozek J, Etxeandia-Ikobaltzeta I, Mustafa RA, Manja V, et al. GRADE evidence to decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT. J Clin Epidemiol. 2017;81:101\u201310.","journal-title":"J Clin Epidemiol"},{"issue":"10047","key":"1493_CR14","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S0140-6736(16)00278-6","volume":"388","author":"S De Leo","year":"2016","unstructured":"De Leo S, Lee SY, Braverman LE. Hyperthyroidism. Lancet. 2016;388(10047):906\u201318.","journal-title":"Lancet"},{"key":"1493_CR15","unstructured":"Alam\u00b9 Z, Shah M, Khan M, Ali W, Shehzad A, Shah JA, et al. Thyroid dysfunction and prevalence of both clinical and subclinical form of hyperthyroidism and hypothyroidism in District Mardan, KPK, Pakistan. 2019;8:98\u2013104."},{"key":"1493_CR16","doi-asserted-by":"crossref","unstructured":"Alvi AM, Azmat U, Shafiq W, Rasheed AHA, Siddiqi AI, Khan S, et al. Efficacy of radioiodine therapy in patients with primary hyperthyroidism: an institutional review from Pakistan.\u00a0Cureus. 2022;14(5).","DOI":"10.7759\/cureus.24992"},{"issue":"2","key":"1493_CR17","first-page":"284","volume":"17","author":"S Sarwar","year":"2013","unstructured":"Sarwar S. Iodized salt: a risk factor for hyperthyroidism. J Rawalpindi Med Coll. 2013;17(2):284\u20137.","journal-title":"J Rawalpindi Med Coll"},{"key":"1493_CR18","doi-asserted-by":"crossref","unstructured":"Olmos RD, De Figueiredo R, Aquino E, Lotufo P, Bensenor IM. Gender, race and socioeconomic influence on diagnosis and treatment of thyroid disorders in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Braz J Med Biol Res. 2015;48:751-8.","DOI":"10.1590\/1414-431x20154445"},{"issue":"2","key":"1493_CR19","first-page":"85","volume":"8","author":"S Shaffique","year":"2020","unstructured":"Shaffique S, Anwar H, Asif HM, ul Haq I, Akram MJRJP, Sciences P. Prevalence of hyperthyroidism and its impact on Quality of Life among students of the Islamia. Univ Bahawalpur Pakistan. 2020;8(2):85\u201390.","journal-title":"Univ Bahawalpur Pakistan"},{"issue":"2","key":"1493_CR20","first-page":"167.e1","volume":"2","author":"P Alonso-Coello","year":"2017","unstructured":"Alonso-Coello P, Oxman AD, Moberg J, Brignardello-Petersen R, Akl EA, Davoli M, et al. GRADE evidence to decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. Clin Pract Guidelines. 2017;2(2):167.e1-e10.","journal-title":"Clin Pract Guidelines"},{"issue":"Suppl 5","key":"1493_CR21","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1186\/s12889-017-4867-6","volume":"17","author":"AD Okely","year":"2017","unstructured":"Okely AD, Ghersi D, Hesketh KD, Santos R, Loughran SP, Cliff DP, et al. A collaborative approach to adopting\/adapting guidelines - the Australian 24-hour movement guidelines for the early years (birth to 5 years): an integration of physical activity, sedentary behavior, and sleep. BMC Public Health. 2017;17(Suppl 5):869.","journal-title":"BMC Public Health"},{"issue":"1","key":"1493_CR22","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12961-021-00731-z","volume":"19","author":"LA Kahale","year":"2021","unstructured":"Kahale LA, Ouertatani H, Brahem AB, Grati H, Hamouda MB, Saz-Parkinson Z, et al. Contextual differences considered in the Tunisian ADOLOPMENT of the European guidelines on breast cancer screening. Health Res Policy Syst. 2021;19(1):80.","journal-title":"Health Res Policy Syst"},{"issue":"1","key":"1493_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12955-017-0754-1","volume":"15","author":"A Darzi","year":"2017","unstructured":"Darzi A, Harfouche M, Arayssi T, Alemadi S, Alnaqbi KA, Badsha H, et al. Adaptation of the 2015 American College of Rheumatology treatment guideline for rheumatoid arthritis for the Eastern Mediterranean Region: an exemplar of the GRADE Adolopment. Health Qual Life Outcomes. 2017;15(1):183.","journal-title":"Health Qual Life Outcomes"},{"key":"1493_CR24","doi-asserted-by":"crossref","unstructured":"Loo BKG, Okely AD, Pulungan A, Jalaludin MY. Asia-Pacific Consensus Statement on integrated 24-hour activity guidelines for children and adolescents. 2022;56(10):539\u2009\u2212\u200945.","DOI":"10.1136\/bjsports-2021-104527"},{"key":"1493_CR25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jclinepi.2020.10.022","volume":"131","author":"R Coronado","year":"2020","unstructured":"Coronado R, G\u00f3mez de Le\u00f3n AO, Faba-Beaumont M. Adaptation of clinical practice guidelines for osteoporosis in a Mexican context. Experience using methodologies ADAPTE, GRADE-ADOLOPMENT and RAND\/UCLA. J Clin Epidemiol. 2020;131:30\u201342.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"1493_CR26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1123\/jpah.2019-0139","volume":"17","author":"JJ Reilly","year":"2020","unstructured":"Reilly JJ, Hughes AR, Janssen X, Hesketh KR, Livingstone S, Hill C, et al. GRADE-ADOLOPMENT process to develop 24-hour movement behavior recommendations and physical activity guidelines for the under 5s in the United Kingdom, 2019. J Phys Act Health. 2020;17(1):101\u20138.","journal-title":"J Phys Act Health"},{"key":"1493_CR27","unstructured":"Society PE. Publication & trials. Available from: https:\/\/www.pakendosociety.org\/publications-trials\/."},{"key":"1493_CR28","unstructured":"Haq IU, Rehman ZU. Medical Research in Pakistan; A Bibliometric Evaluation from 2001 to 2020. Libr Philos Pract. 2021:1\u201313."},{"key":"1493_CR29","unstructured":"Bhatti MW. Country facing shortage of internal medicine specialists owing to non-practising female doctors. Pakistan: The News International; 2022. thenews.com.pk."},{"key":"1493_CR30","doi-asserted-by":"crossref","unstructured":"RossDouglas S, BurchHenry B, CooperDavid S, Carol G, Luiza M, RivkeesScott A, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26(10):1343\u20131421.","DOI":"10.1089\/thy.2016.0229"},{"key":"1493_CR31","unstructured":"GRADEpro G, GRADEpro GDT. GRADEpro Guideline Development Tool [Software]. McMaster University, 2015 (developed by Evidence Prime, Inc.); 2015."},{"issue":"10","key":"1493_CR32","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1089\/thy.2019.0045","volume":"29","author":"N Suzuki","year":"2019","unstructured":"Suzuki N, Noh JY, Hiruma M, Kawaguchi A, Morisaki M, Ohye H, et al. Analysis of antithyroid drug-Induced severe liver Injury in 18,558 newly diagnosed patients with Graves\u2019 disease in Japan. Thyroid. 2019;29(10):1390\u20138.","journal-title":"Thyroid"},{"key":"1493_CR33","unstructured":"Statistics PBo. Government of Pakistan Bureau of Statistics Karachi. 2021. Available from: https:\/\/www.pbs.gov.pk."},{"issue":"10","key":"1493_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5539\/gjhs.v12n10p14","volume":"12","author":"AR Cheema","year":"2020","unstructured":"Cheema AR, Zaidi S, Najmi R, Khan FA, Kori SA, Shah NA. Availability does not mean utilisation: analysis of a large micro health insurance programme in Pakistan. Global J Health Sci. 2020;12(10):1\u20134.","journal-title":"Global J Health Sci"},{"issue":"6","key":"1493_CR35","first-page":"309","volume":"58","author":"LM Zuberi","year":"2008","unstructured":"Zuberi LM, Awan S, Islam N, Akhter J, Jabbar A. Does choice of therapy save costs and improve outcomes in hyperthyroid patients. J Pak Med Assoc. 2008;58(6):309.","journal-title":"J Pak Med Assoc"},{"issue":"10","key":"1493_CR36","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1007\/s00268-020-05593-0","volume":"44","author":"K Lindner","year":"2020","unstructured":"Lindner K, Ku\u00dfmann J, Fendrich V. Preoperative potassium iodide treatment in patients undergoing thyroidectomy for Graves\u2019 disease\u2014perspective of a European high-volume center. World J Surg. 2020;44(10):3405\u20139.","journal-title":"World J Surg"},{"issue":"1","key":"1493_CR37","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.surg.2017.03.030","volume":"163","author":"RW Randle","year":"2018","unstructured":"Randle RW, Bates MF, Long KL, Pitt SC, Schneider DF, Sippel RS. Impact of potassium iodide on thyroidectomy for Graves\u2019 disease: implications for safety and operative difficulty. Surgery. 2018;163(1):68\u201372.","journal-title":"Surgery"},{"key":"1493_CR38","unstructured":"Kalra S, Kalra B. Mishti copes with diabetes: a pragmatic approach to coping skills training. J Soc Health Diabetes; New York. 2015;5(1):1\u20132."}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-023-01493-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-023-01493-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-023-01493-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T04:38:13Z","timestamp":1710995893000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-023-01493-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,21]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1493"],"URL":"https:\/\/doi.org\/10.1186\/s12902-023-01493-1","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,21]]},"assertion":[{"value":"31 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Given the lack of involvement of patients or other human participants, a waiver of ethics approval and informed consent was obtained from the Ethics Review Committee of the Aga Khan University. All methods were conducted in accordance with the highest ethical standards outlined in the 1964 Declaration of Helsinki and its future amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}